Q2 2021 Holdings
Filed 2021-08-11 | 67 holdings | $55.9M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $25.2M | 149,000 | 45.2% |
| Biogen Inc(BIIB) | COM | 09062X103 | $16.8M | 48,500 | 30.0% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $4.6M | 55,156 | 8.2% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $3.9M | 298,500 | 6.9% |
| Ascendis Pharma AS(ASND) | Sponsored ADR | 04351P101 | $1.8M | 13,800 | 3.2% |
| Agios Pharmaceuticals Inc(AGIO) | COM | 00847X104 | $1.2M | 21,500 | 2.1% |
| Axsome Therapeutics Inc(AXSM) | COM | 05464T104 | $944.0K | 14,000 | 1.7% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $591.0K | 78,000 | 1.1% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $535.0K | 44,000 | 1.0% |
| Gilead Sciences Inc(GILD) | COM | 375558103 | $27.7K | 402,784 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $22.9K | 145,000 | 0.0% |
| Horizon Therapeutics PUB LTD | SHS | G4617B105 | $22.3K | 237,873 | 0.0% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $20.8K | 37,200 | 0.0% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $20.1K | 207,000 | 0.0% |
| PTC Therapuetics COM(PTCT) | COM | 69366J200 | $18.9K | 449,000 | 0.0% |
| Biohaven Pharmactl Hldg Co L(BHVN) | COM | G11196105 | $17.1K | 176,400 | 0.0% |
| Vertex Pharmaceuticals Inc(VRTX) | COM | 92532F100 | $13.1K | 64,822 | 0.0% |
| Amgen Inc(AMGN) | COM | 031162100 | $12.4K | 51,000 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $11.5K | 136,860 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $9.7K | 315,500 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $9.5K | 121,541 | 0.0% |
| United Therapeutics Corp del(UTHR) | COM | 91307C102 | $7.8K | 43,300 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $7.6K | 60,500 | 0.0% |
| Ionis Pharmaceuticals Inc(IONS) | COM | 462222100 | $7.3K | 181,781 | 0.0% |
| Protagonist Therapeutics Inc(PTGX) | COM | 74366E102 | $6.8K | 152,000 | 0.0% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $6.8K | 283,233 | 0.0% |
| Supernus Pharmaceuticals Inc(SUPN) | COM | 868459108 | $6.2K | 202,436 | 0.0% |
| Ultragenyx Pharmaceutical in(RARE) | COM | 90400D108 | $5.7K | 60,100 | 0.0% |
| Harmony Biosciences Hldgs in(HRMY) | COM | 413197104 | $4.7K | 166,000 | 0.0% |
| Chemocentryx Inc(CCXIEUR) | COM | 16383L106 | $4.0K | 58,100 | 0.0% |
| Halozyme Therapeutics Inc(HALO) | COM | 40637H109 | $3.8K | 82,633 | 0.0% |
| Deciphera Pharmaceuticals Inc(DCPHEUR) | COM | 24344T101 | $3.7K | 100,000 | 0.0% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $3.6K | 20,000 | 0.0% |
| Intra Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $3.2K | 79,456 | 0.0% |
| Insmed Inc(INSM) | COM | 457669307 | $2.8K | 100,100 | 0.0% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $2.8K | 135,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $2.7K | 16,900 | 0.0% |
| Hutchmed China LTD(HCM) | SPONSORED ADS | 44842L103 | $2.7K | 68,000 | 0.0% |
| Sutro Biopharma Inc | COM | 869367102 | $2.6K | 139,331 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $2.5K | 31,500 | 0.0% |
| Chinook Therapeutics Inc(290A) | COM | 16961L106 | $2.4K | 170,821 | 0.0% |
| ZAI LAB LTD(ZLAB) | ADR | 98887Q104 | $2.3K | 12,800 | 0.0% |
| Nkarta Inc(NKTX) | COM | 65487U108 | $2.2K | 70,000 | 0.0% |
| Guardant Health Inc(GH) | COM | 40131M109 | $2.1K | 17,000 | 0.0% |
| Exelixis Inc(EXEL) | COM | 30161Q104 | $1.9K | 101,534 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $1.7K | 19,500 | 0.0% |
| Iovance Biotherapeutics Inc(IOVA) | COM | 462260100 | $1.5K | 58,000 | 0.0% |
| Enanta Pharmaceuticals Inc(ENTA) | COM | 29251M106 | $1.5K | 34,047 | 0.0% |
| Apellis Pharmaceuticals Inc(APLS) | CM | 03753U106 | $1.5K | 23,400 | 0.0% |
| Arena Pharmaceuticals Inc(ARNAEUR) | COM NEW | 040047607 | $1.4K | 21,000 | 0.0% |